GSA Capital Partners LLP Has $252,000 Stock Position in Seer, Inc. (NASDAQ:SEER)

GSA Capital Partners LLP raised its holdings in Seer, Inc. (NASDAQ:SEER) by 194.9% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 127,868 shares of the company’s stock after acquiring an additional 84,515 shares during the period. GSA Capital Partners LLP’s holdings in Seer were worth $252,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SEER. AQR Capital Management LLC acquired a new stake in shares of Seer during the 2nd quarter worth approximately $30,000. Point72 DIFC Ltd acquired a new stake in shares of Seer during the 2nd quarter worth approximately $35,000. Quadrature Capital Ltd acquired a new stake in shares of Seer during the 1st quarter worth approximately $56,000. American Century Companies Inc. boosted its stake in Seer by 42.1% in the 2nd quarter. American Century Companies Inc. now owns 61,752 shares of the company’s stock valued at $104,000 after buying an additional 18,302 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in Seer by 74.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 59,580 shares of the company’s stock valued at $114,000 after buying an additional 25,441 shares in the last quarter. Institutional investors and hedge funds own 75.20% of the company’s stock.

Seer Trading Up 2.1 %

NASDAQ:SEER opened at $2.43 on Friday. Seer, Inc. has a 1 year low of $1.51 and a 1 year high of $2.53. The stock has a market cap of $143.29 million, a price-to-earnings ratio of -1.87 and a beta of 1.45. The stock has a 50-day moving average price of $2.00 and a two-hundred day moving average price of $1.87.

Analysts Set New Price Targets

Separately, Morgan Stanley cut their price objective on Seer from $7.00 to $3.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 13th.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.